Lanexa Biologics

Lanexa Biologics is a private biotechnology company based in Virginia that specializes in the development of recombinant protein-based therapeutics and vaccines. The company leverages a proprietary protein expression platform designed to produce complex biologics with high efficiency and scalability. Lanexa's primary research focus has been directed toward addressing infectious diseases, most notably through the development of a recombinant subunit vaccine candidate for COVID-19. By utilizing advanced molecular engineering, the company aims to create stable and potent immunogens that can be manufactured at a lower cost than traditional cell-culture methods. Lanexa Biologics continues to explore applications for its platform in oncology and other therapeutic areas requiring high-quality recombinant proteins.